Soma: Medgend

Soma FDA Approved Drugs

CARISOPRODOL [Carisoprodol^{C₁₂H₂₄N₂O₄}]

250mg (oral tablet)

350mg (oral tablet)

Aurobindo Pharma^{Nov 8, 2016}
Nostrum Labs Inc^{May 11, 2017}
Strides Pharma^{Nov 12, 2015}
Wilshire Pharms Inc^{Jul 8, 2015}
Accelrx Labs^{Jun 7, 2005}
Hikma Intl Pharms^{Jan 24, 1996}
Ingenus Pharms Nj^{Oct 22, 2008}
Natco Pharma Ltd^{Oct 28, 2014}
Orient Pharma Co Ltd^{Oct 28, 2014}
Sciegen Pharms Inc^{Jan 27, 2014}
Sun Pharm Inds^{Oct 17, 1991}
Sun Pharm Inds Ltd^{Feb 27, 2007}
Vintage Pharms^{Sep 8, 1997}
Watson Labs^{Apr 20, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CARISOPRODOL AND ASPIRIN [Aspirin^C₉H₈O₄ : Carisoprodol^{C₁₂H₂₄N₂O₄}]

325mg : 200mg (oral tablet)

Heritage Pharms Inc^{Mar 31, 1989}
Ingenus Pharms Nj^{Jan 7, 2010}
Oxford Pharms^{Dec 10, 1997}
Sandoz^{Apr 25, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE [Aspirin^C₉H₈O₄ : Carisoprodol^{C₁₂H₂₄N₂O₄} : Codeine Phosphate^{2C₁₈H₂₁NO₃H₂O2H₃O₄P}]

325mg : 200mg : 16mg (oral tablet)

Ingenus Pharms Nj^{Jan 7, 2010}
Sandoz^{Apr 16, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DOXIL (LIPOSOMAL) [Doxorubicin Hydrochloride^{C₂₇H₂₉NO₁₁ClH}]

20mg/10ml (2mg/ml) (injection injectable, liposomal)

50mg/25ml (2mg/ml) (injection injectable, liposomal)

Janssen Res And Dev^{Nov 17, 1995}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DOXORUBICIN HYDROCHLORIDE [Doxorubicin Hydrochloride^{C₂₇H₂₉NO₁₁ClH}]

10mg/vial (injection injectable)

150mg/75ml (injection injectable)

200mg/100ml (injection injectable)

20mg/vial (injection injectable)

2mg/ml (injection injectable)

50mg/vial (injection injectable)

Mylan Labs Ltd^{Oct 28, 2011}
Pharmachemie Bv^{May 21, 1990}
West-ward Pharms Int^{Mar 17, 1989}
Pharmacia And Upjohn^{Mar 28, 2011}
Actavis Inc^{Jun 27, 2014}
Teva Pharms Usa^{Jul 28, 1995}
Amneal Pharms Co^{Feb 17, 2017}
Alvogen Inc^{Nov 8, 2012}
Fresenius Kabi Usa^{Oct 26, 1995}
Sagent Pharms^{Mar 18, 2013}
Sun Pharm Inds^{Feb 15, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) [Doxorubicin Hydrochloride^{C₂₇H₂₉NO₁₁ClH}]

20mg/10ml (2mg/ml) (injection injectable, liposomal)

50mg/25ml (2mg/ml) (injection injectable, liposomal)

Dr Reddys Labs Ltd^{May 15, 2017}
Sun Pharma Global^{Feb 4, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GENOTROPIN [Somatropin Recombinant]

13.8mg/vial (injection injectable)

5.8mg/vial (injection injectable)

Pharmacia And Upjohn^{Oct 23, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GENOTROPIN PRESERVATIVE FREE [Somatropin Recombinant]

0.2mg/vial (injection injectable)

0.4mg/vial (injection injectable)

0.6mg/vial (injection injectable)

0.8mg/vial (injection injectable)

1.2mg/vial (injection injectable)

1.4mg/vial (injection injectable)

1.5mg/vial (injection injectable)

1.6mg/vial (injection injectable)

1.8mg/vial (injection injectable)

1mg/vial (injection injectable)

Pharmacia And Upjohn^{Jan 27, 1998}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

HUMATROPE [Somatropin Recombinant]

12mg/vial (injection injectable)

24mg/vial (injection injectable)

5mg/vial (injection injectable)

6mg/vial (injection injectable)

Lilly^{Feb 4, 1999}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

JUXTAPID [Lomitapide Mesylate^{C₃₉H₃₇F₆N₃O₂CH₄O₃S}]

eq 10mg base (oral capsule)

eq 20mg base (oral capsule)

eq 30mg base (oral capsule)

eq 40mg base (oral capsule)

eq 5mg base (oral capsule)

eq 60mg base (oral capsule)

Aegerion^{Dec 21, 2012}

A dosing regimen for the treatment of hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia using at least three step-wise increasing doses.
A dosing regimen for the treatment of hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia using at least three step-wise increasing doses.
Treatment of hypercholesterolemia by decreasing the amount or activity of microsomal triglyceride transfer protein in patients with homozygous familial hypercholesterolemia.
Treatment of hypercholesterolemia, hyperlipidemia and hyperlipoproteinemia in patients with homozygous familial hypercholesterolemia.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

NORDITROPIN FLEXPRO [Somatropin Recombinant]

10mg/1.5ml (injection injectable)

15mg/1.5ml (injection injectable)

30mg/3ml (injection injectable)

Novo Nordisk Inc^{Mar 1, 2010}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

NUTROPIN AQ NUSPIN [Somatropin Recombinant]

10mg/2ml (5mg/ml) (injection injectable)

20mg/2ml (10mg/ml) (injection injectable)

5mg/2ml (2.5mg/ml) (injection injectable)

Genentech^{Jan 3, 2008}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

NUTROPIN AQ PEN [Somatropin Recombinant]

10mg/2ml (5mg/ml) (injection injectable)

20mg/2ml (10mg/ml) (injection injectable)

Genentech^{Apr 22, 2002}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

OMNITROPE [Somatropin Recombinant]

1.5mg/vial (injection injectable)

10mg/1.5ml (injection injectable)

5.8mg/vial (injection injectable)

5mg/1.5ml (injection injectable)

Sandoz^{May 30, 2006}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SAIZEN [Somatropin Recombinant]

5mg/vial (injection injectable)

8.8mg/vial (injection injectable)

Emd Serono^{Oct 8, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SEROSTIM [Somatropin Recombinant]

4mg/vial (injection injectable)

5mg/vial (injection injectable)

6mg/vial (injection injectable)

Emd Serono^{Jul 25, 1997}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SOMA [Carisoprodol^{C₁₂H₂₄N₂O₄}]

250mg (oral tablet)

350mg (oral tablet)

Mylan Speciality Lp^{Sep 13, 2007}

efficacy
0.0 (0)

side effects
0.0 (0)

SOMATULINE DEPOT [Lanreotide Acetate^{2C₅₄H₆₉N₁₁O₁₀S₂5C₂H₄O₂}]

eq 120mg base/0.5ml (eq 120mg base/0.5ml) (subcutaneous solution)

eq 60mg base/0.2ml (eq 60mg base/0.2ml) (subcutaneous solution)

eq 90mg base/0.3ml (eq 90mg base/0.3ml) (subcutaneous solution)

Ipsen Pharma^{Aug 30, 2007}

Method of administering lanreotide acetate.

SOMAVERT [Pegvisomant]

10mg/vial (subcutaneous injectable)

15mg/vial (subcutaneous injectable)

20mg/vial (subcutaneous injectable)

25mg/vial (subcutaneous injectable)

30mg/vial (subcutaneous injectable)

Pharmacia And Upjohn^{Mar 25, 2003}

VALTROPIN [Somatropin Recombinant]

5mg/vial (injection injectable)

Lg Chem Ltd^{Apr 19, 2007}

XERMELO [Telotristat Etiprate^{C₂₇H₂₆ClF₃N₆O₃C₉H₉NO₃}]

eq 250mg base (oral tablet)

Lexicon Pharms Inc^{Feb 28, 2017}

The treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (ssa) therapy in adults inadequately controlled by ssa therapy.

ZOMACTON [Somatropin Recombinant]

10mg/vial (injection injectable)

5mg/vial (injection injectable)

Ferring^{Mar 7, 2012}

ZORBTIVE [Somatropin Recombinant]

8.8mg/vial (injection injectable)

Emd Serono^{Dec 1, 2003}

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Soma

CHIONANTHUS
The bark of the root of Chionanthus virginicus, Linné. (Nat. Ord. Oleaceae.) United States from Pennsylvania southward. Dose, 5 to 30... / ... living, and is a remedy of considerable value in the gastro-intestinal and hepatic disorders of dipsomania. It has been asserted by many whose large experience entitles them to credence that chionant... / ...never reach the true diabetic state. There is good reason to believe that the prolonged use of chionanthus will be of much benefit in such cases.¹

Physician's Therapeutics Memoranda on Soma

DIPSOMANIA
The treatment must be largely moral, but sustaining agents such as coca are important. The remedies having most effect are salts of gold (especially Solution Gold and Arsenic Bromide, N., B. & Co.); pilocarpine, tartar emetic, lupulin and capsicum.²

References

1) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.
2) Nelson, Baker & Co., 1904, Physician's Handy Book of Materia Medica and Therapeustics, Detroit, Michigan.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Soma FDA Approved Drugs

Felter's Materia Medica on Soma

Physician's Therapeutics Memoranda on Soma

References